Literature DB >> 24412314

Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study.

Haejun Song1, Jeongdeuk Lee2, Muhyung Lee3, Won Suk Choi4, Jung Hyun Choi5, Mi Suk Lee6, Mahdi Hashemi7, Emmanouil Rampakakis8, Kosuke Kawai9, Ron White10, Camilo Acosta10, John S Sampalis8, Hee Jin Cheong11.   

Abstract

OBJECTIVES: To assess the herpes zoster (HZ) disease burden, including the severity and duration of HZ-associated pain, its impact on quality of life (QoL), and healthcare resource utilization (HCRU) in a South Korean clinical setting.
METHODS: Patients aged ≥50 years were followed prospectively for ≤6 months. Based on the duration of their episode at enrollment, cases were classified as incident (<7 days) or prevalent (≥7 days). HZ pain and discomfort were measured with the HZ Severity of Illness (HZ-SOI) severity-by-duration composite score.
RESULTS: One hundred fifty-one patients (69.5% prevalent cases) were enrolled. Prodrome pain was experienced by 68.2% of patients, of whom 95.1% experienced moderate-to-severe pain; post-herpetic neuralgia was experienced by 38.4%. Prevalent disease, higher acute pain, and older age were significant predictors of greater HZ-SOI, while use of antivirals was associated with decreased HZ-SOI. HZ-associated pain was associated with reduced QoL and affected all daily living activities (particularly mood, life enjoyment, general activities, and sleep), resulting in significant HCRU, including primary care doctor, specialist, or physiotherapist consultations, hospitalizations, and emergency department visits.
CONCLUSION: Severe morbidity, impaired QoL, and significant HCRU are associated with HZ in South Korea, especially in older patients, supporting the need for early intervention and preventive strategies to reduce the HZ-associated disease burden.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Burden of illness; Herpes zoster; Observational; Pain; Quality of life; South Korea

Mesh:

Year:  2014        PMID: 24412314     DOI: 10.1016/j.ijid.2013.11.018

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  20 in total

1.  Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.

Authors:  Tae Un Yang; Hee Jin Cheong; Joon Young Song; Ji Yun Noh; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Reducing the burden of Herpes Zoster in Italy.

Authors:  Giovanni Gabutti; Elisabetta Franco; Paolo Bonanni; Michele Conversano; Antonio Ferro; Marzia Lazzari; Stefania Maggi; Alessandro Rossi; Silvestro Scotti; Francesco Vitale; Antonio Volpi; Donato Greco
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Physician Attitudes toward the Herpes Zoster Vaccination in South Korea.

Authors:  Tae Un Yang; Hee Jin Cheong; Won Suk Choi; Joon Young Song; Ji Yun Noh; Woo Joo Kim
Journal:  Infect Chemother       Date:  2014-09-24

4.  Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study.

Authors:  Myong-Joo Hong; Yeon-Dong Kim; Yong-Kwan Cheong; Seon-Jeong Park; Seung-Won Choi; Hyon-Joo Hong
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  A Study of Intravenous Administration of Vitamin C in the Treatment of Acute Herpetic Pain and Postherpetic Neuralgia.

Authors:  Min Sung Kim; Dong Jin Kim; Chan Ho Na; Bong Seok Shin
Journal:  Ann Dermatol       Date:  2016-11-23       Impact factor: 1.444

6.  Fulranumab in Patients With Pain Associated With Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety, and Tolerability Results From a Randomized, Double-blind, Placebo-controlled, Phase-2 Study.

Authors:  Hao Wang; Gary Romano; Margaret Fedgchin; Lucille Russell; Panna Sanga; Kathleen M Kelly; Mary Ellen Frustaci; John Thipphawong
Journal:  Clin J Pain       Date:  2017-02       Impact factor: 3.442

7.  Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.

Authors:  Emmanouil Rampakakis; Melissa Stutz; Kosuke Kawai; Tsen-Fang Tsai; Hee Jin Cheong; Jittima Dhitavat; Alejandro Ortiz-Covarrubias; Miguel Cashat-Cruz; Homero Monsanto; Kelly D Johnson; John S Sampalis; Camilo J Acosta
Journal:  Health Qual Life Outcomes       Date:  2017-01-18       Impact factor: 3.186

8.  Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study.

Authors:  Akiko Mizukami; Keiko Sato; Koichi Adachi; Sean Matthews; Katsiaryna Holl; Taizo Matsuki; Toshihiko Kaise; Desmond Curran
Journal:  Clin Drug Investig       Date:  2018-01       Impact factor: 2.859

9.  Healthcare utilization and costs among patients with herpes zoster and solid tumor malignancy on chemotherapy: A retrospective cohort study.

Authors:  Jianbin Mao; Jeffrey T McPheeters; Lyn Finelli
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults.

Authors:  Won Suk Choi; Jung-Hyun Choi; Jun Yong Choi; Joong Sik Eom; Sang Il Kim; Hyunjoo Pai; Kyong Ran Peck; Jang Wook Sohn; Hee Jin Cheong
Journal:  J Korean Med Sci       Date:  2015-12-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.